Inventor · disambiguated record
Jean-Louis Mergny
Also filed as: MERGNY JEAN-LOUIS
10 granted patents·14 pending applications·55 citations·filing 2000–2022
86Inventor score
Files withINST NAT SANTE RECH MED7AVENTIS PHARMA SA6AVENTIS PHARMS S A1INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA REC HERCHE MÉDICALE)1INSERM INSTITUT NAT DE LA SANTE ETDE LA RECH MEDICALE1
Top patents by PatentIndex Score
24 records- 0189US6645964B1Chemical derivatives and their application as antitelomerase agentAVENTIS PHARMA SA·Filed 2000·Granted Nov 11, 2003·34 cites·19 claims
- 0276US6887873B2Triazine derivatives and their application as antitelomerase agentsAVENTIS PHARMA SA·Filed 2002·Granted May 3, 2005·7 cites·34 claims
- 0375US7179816B2Chemical derivatives and their application as antitelomerase agentsAVENTIS PHARMA SA·Filed 2004·Granted Feb 20, 2007·6 cites·10 claims
- 0474US6858608B2Chemical derivatives and their application as antitelomerase agentsAVENTIS PHARMA SA·Filed 2002·Granted Feb 22, 2005·7 cites·30 claims
- 0571US2023107696A1Derivatives of porphyrins, their process of preparation and their use for treating viral infectionsINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0669US10577375B2Derivatives of porphyrins, their process of preparation and their use for treating viral infectionsINST NAT SANTE RECH MED·Filed 2016·Granted Mar 3, 2020·1 cites·5 claims
- 0765US2021253591A1Derivatives of porphyrins, their process of preparation and their use for treating viral infectionsINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0861US11046704B2Derivatives of porphyrins, their process of preparation and their use for treating viral infectionsINST NAT SANTE RECH MED·Filed 2020·Granted Jun 29, 2021·0 cites·6 claims
- 0961US2009226411A1Chemical derivatives and their application as antitelomerase agentsAVENTIS PHARMA SA·Filed 2008·Application pending·0 cites
- 1052US7482352B2Chemical derivatives and their application as antitelomerase agentsAVENTIS PHARMA SA·Filed 2004·Granted Jan 27, 2009·0 cites·12 claims
- 1151US10435691B2Methods and pharmaceutical compositions for the treatment of filovirus infectionsINST NAT SANTE RECH MED·Filed 2018·Granted Oct 8, 2019·0 cites·5 claims
- 1248US2011201648A1Poly-heteroaryl derivatives for the treatment of cancerINST CURIE·Filed 2009·Application pending·0 cites
- 1347US2023212146A1Triarylpyridine compounds and use thereof for treating cancerINSTITUT NATIONAL DE LA SANTEET DE LA RECH MEDICALE INSERM·Filed 2021·Application pending·0 cites
- 1446US10160970B2Methods and pharmaceutical compositions for the treatment of filovirus infectionsINST NAT SANTE RECH MED·Filed 2016·Granted Dec 25, 2018·0 cites·6 claims
- 1545US11492366B2Platinum compounds for binding guanine quadruplexesUNIV KINGSTON·Filed 2018·Granted Nov 8, 2022·0 cites·18 claims
- 1644US2002103169A1Chemical derivatives and use thereof as antitelomerase agentsFiled 2001·Application pending·0 cites
- 1744US2008119492A1Compositions and methods for treating cancer and other diseases characterized by abnormal cell proliferationLEHN JEAN-MARIE·Filed 2006·Application pending·0 cites
- 1844US2025360134A16-6 or 5-6 fused bicyclic compounds comprising a pyri(mi)dine ring useful in the|treatment of infectious diseasesINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 1942US2007232572A1Chemical derivatives as antitelomerase agents which bind specifically to the G-quadruplex DNA structures and their application as a specific anticancer agentUNIV REIMS CHAMPAGNE ARDENNE·Filed 2004·Application pending·0 cites
- 2041US2004053966A1Chemical derivatives and their application as antitelomerase agentAVENTIS PHARMS S A·Filed 2003·Application pending·0 cites
- 2134US2003013711A1Chemical derivatives and their application as antitelomerase agentsFiled 2002·Application pending·0 cites
- 2231US2004034023A1Use of polycyclic aromatic compounds for making medicines capable of inhibiting telomeraseFiled 2001·Application pending·0 cites
- 2327US2018036427A1Methods and pharmaceutical compositions for the treatment of hiv infectionINSERM INSTITUT NAT DE LA SANTE ETDE LA RECH MEDICALE·Filed 2016·Application pending·0 cites
- 2427US2017191059A1Nucleic acids acting as decoys for the treatment of lentivirus infectionINSERM (INSTITUT NAT DE LA SANTÉ ET DE LA REC HERCHE MÉDICALE)·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jean-Louis Mergny files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →